CRISPR Therapeutics AG
CRSPHealthcare|Biotechnology|Switzerland
$48.44
-0.71 (-1.44%)
Tangible Book
$20.04
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (203)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| KASINGER JAMES R. | General Counsel and Secretary | 2026-03-23 | SELL | 3,182 | $46.78 | $148.9K |
| Kulkarni Samarth | CEO | 2026-03-23 | SELL | 10,020 | $46.78 | $468.7K |
| Prasad Raju | CFO | 2026-03-23 | SELL | 3,708 | $46.78 | $173.5K |
| Patel Naimish | Chief Medical Officer | 2026-03-16 | SELL | 3,150 | $48.26 | $152K |
| Prasad Raju | CFO | 2026-03-16 | SELL | 9,869 | $48.26 | $476.3K |
| KASINGER JAMES R. | General Counsel and Secretary | 2026-03-16 | SELL | 3,450 | $48.26 | $166.5K |
| Kulkarni Samarth | CEO | 2026-03-16 | SELL | 10,349 | $48.26 | $499.4K |
| KASINGER JAMES R. | General Counsel and Secretary | 2026-03-11 | SELL | 2,800 | $52.8 | $147.8K |
| Kulkarni Samarth | CEO | 2026-03-11 | SELL | 9,798 | $52.8 | $517.3K |
| Kulkarni Samarth | CEO | 2026-02-19 | SELL | 6,967 | $52.58 | $366.3K |
| KASINGER JAMES R. | General Counsel and Secretary | 2026-02-19 | SELL | 2,112 | $52.58 | $111K |
| Kulkarni Samarth | CEO | 2026-01-22 | SELL | 90,000 | $57.4 | $5166K |
| Prasad Raju | CFO | 2026-01-22 | SELL | 34,972 | $60.19 | $2105K |
| Prasad Raju | CFO | 2026-01-06 | SELL | 29,700 | $60.16 | $1786.8K |
| Kulkarni Samarth | CEO | 2025-10-17 | SELL | 50,895 | $67.91 | $3456.3K |
| Kulkarni Samarth | CEO | 2025-10-14 | SELL | 4,242 | $66.6 | $282.5K |
| KASINGER JAMES R. | General Counsel and Secretary | 2025-10-14 | SELL | 1,076 | $66.6 | $71.7K |
| Kulkarni Samarth | CEO | 2025-08-18 | SELL | 13,081 | $58.15 | $760.7K |
| Treco Douglas A | Director | 2025-08-06 | BUY | 20,000 | $57.03 | $1140.6K |
| George Simeon | Director | 2025-07-16 | BUY | 989,812 | $52.03 | $51499.9K |
| Patel Naimish | Chief Medical Officer | 2025-05-29 | SELL | 3,932 | $35.94 | $141.3K |
| Patel Naimish | Chief Medical Officer | 2025-04-03 | BUY | 1,508 | $32.96 | $49.7K |
| Kulkarni Samarth | CEO | 2025-03-21 | SELL | 10,031 | $41.23 | $413.6K |
| Bruno Julianne | COO | 2025-03-21 | SELL | 1,714 | $41.23 | $70.7K |
| Prasad Raju | CFO | 2025-03-21 | SELL | 2,197 | $41.23 | $90.6K |
| KASINGER JAMES R. | General Counsel and Secretary | 2025-03-21 | SELL | 3,185 | $41.23 | $131.3K |
| Prasad Raju | CFO | 2025-03-17 | SELL | 3,762 | $41.8 | $157.3K |
| Kulkarni Samarth | CEO | 2025-03-12 | SELL | 14,435 | $42.7 | $616.4K |
| KASINGER JAMES R. | General Counsel and Secretary | 2025-03-12 | SELL | 3,966 | $42.67 | $169.2K |
| Bruno Julianne | COO | 2025-03-12 | SELL | 1,388 | $42.54 | $59K |
| Greene John | Director | 2025-02-26 | BUY | 7,000 | $44.85 | $314K |
| Kulkarni Samarth | CEO | 2025-02-19 | SELL | 18,360 | $55.21 | $1013.7K |
| Bruno Julianne | COO | 2025-02-19 | SELL | 333 | $52.8 | $17.6K |
| Kulkarni Samarth | CEO | 2025-02-19 | SELL | 18,568 | $54.21 | $1006.6K |
| KASINGER JAMES R. | General Counsel and Secretary | 2025-02-19 | SELL | 11,542 | $53.67 | $619.5K |
| Kulkarni Samarth | CEO | 2024-12-02 | SELL | 15,000 | $55.1 | $826.5K |
| Kulkarni Samarth | CEO | 2024-11-11 | SELL | 30,000 | $55.62 | $1668.6K |
| KASINGER JAMES R. | General Counsel and Secretary | 2024-10-14 | SELL | 1,089 | $46.28 | $50.4K |
| Kulkarni Samarth | CEO | 2024-10-14 | SELL | 4,293 | $46.28 | $198.7K |
| Bruno Julianne | COO | 2024-06-21 | SELL | 3,366 | $56.09 | $188.8K |
| Kulkarni Samarth | CEO | 2024-04-15 | SELL | 19,582 | $59.91 | $1173.2K |
| Prasad Raju | CFO | 2024-03-15 | SELL | 3,524 | $72.69 | $256.2K |
| Kulkarni Samarth | CEO | 2024-03-15 | SELL | 20,000 | $72.48 | $1449.6K |
| KASINGER JAMES R. | General Counsel and Secretary | 2024-03-12 | SELL | 3,947 | $77.15 | $304.5K |
| Kulkarni Samarth | CEO | 2024-03-12 | SELL | 14,385 | $77.04 | $1108.2K |
| KASINGER JAMES R. | General Counsel and Secretary | 2024-02-20 | SELL | 1,913 | $79.67 | $152.4K |
| Kulkarni Samarth | CEO | 2024-02-20 | SELL | 6,370 | $79.67 | $507.5K |
| Kulkarni Samarth | CEO | 2024-02-15 | SELL | 20,000 | $80.36 | $1607.2K |
| Kulkarni Samarth | CEO | 2024-01-29 | SELL | 50,000 | $60.51 | $3025.5K |
| Kulkarni Samarth | CEO | 2024-01-16 | SELL | 20,000 | $62.5 | $1250K |
| Kulkarni Samarth | CEO | 2023-05-30 | SELL | 25,000 | $64.88 | $1622K |
| Kulkarni Samarth | CEO | 2023-04-25 | SELL | 25,000 | $50.67 | $1266.8K |
| Kulkarni Samarth | CEO | 2023-03-29 | SELL | 25,000 | $44.46 | $1111.5K |
| Kulkarni Samarth | CEO | 2023-02-27 | SELL | 25,000 | $48.25 | $1206.3K |
| Kulkarni Samarth | CEO | 2023-01-27 | SELL | 25,000 | $51.47 | $1286.8K |
| Kulkarni Samarth | CEO | 2022-12-28 | SELL | 25,000 | $40.93 | $1023.3K |
| Kulkarni Samarth | CEO | 2022-11-28 | SELL | 25,000 | $54.03 | $1350.8K |
| Kulkarni Samarth | CEO | 2022-10-26 | SELL | 25,000 | $54.81 | $1370.3K |
| Kulkarni Samarth | CEO | 2022-09-28 | SELL | 25,000 | $64.61 | $1615.3K |
| Kulkarni Samarth | CEO | 2022-08-29 | SELL | 25,000 | $66.84 | $1671K |
| Kulkarni Samarth | CEO | 2022-07-27 | SELL | 25,000 | $75.91 | $1897.8K |
| Kulkarni Samarth | CEO | 2022-06-29 | SELL | 25,000 | $61.59 | $1539.8K |
| TOMSICEK MICHAEL JOHN | CFO | 2021-08-06 | SELL | 25,000 | $138.52 | $3463K |
| Kulkarni Samarth | CEO | 2021-08-05 | SELL | 30,000 | $128.78 | $3863.4K |
| Bolzon Bradley J PhD | Director | 2021-07-19 | SELL | 10,000 | $126.43 | $1264.3K |
| Novak Rodger | President | 2021-06-30 | SELL | 25,000 | $165 | $4125K |
| Bolzon Bradley J PhD | Director | 2021-06-29 | SELL | 47,536 | $149.49 | $7106.2K |
| Bolzon Bradley J PhD | Director | 2021-06-28 | SELL | 30,375 | $152.48 | $4631.6K |
| Novak Rodger | President | 2021-06-21 | SELL | 25,000 | $128.62 | $3215.5K |
| Kulkarni Samarth | CEO | 2021-06-15 | SELL | 30,000 | $126.43 | $3792.9K |
| Bolzon Bradley J PhD | Director | 2021-06-11 | SELL | 10,000 | $126.61 | $1266.1K |
| Klein Lawrence Otto | CBO & COO | 2021-03-23 | SELL | 100,000 | $128.05 | $12805K |
| Bolzon Bradley J PhD | Director | 2021-03-22 | SELL | 30,374 | $132.37 | $4020.6K |
| Bolzon Bradley J PhD | Director | 2021-02-19 | SELL | 171,003 | $149.11 | $25498.3K |
| KASINGER JAMES R. | General Counsel and Secretary | 2021-01-19 | SELL | 27,500 | $204.94 | $5635.9K |
| Kulkarni Samarth | CEO | 2021-01-15 | SELL | 20,000 | $213.67 | $4273.4K |
| Klein Lawrence Otto | CBO & COO | 2021-01-15 | SELL | 25,000 | $215.2 | $5380K |
| Ho Tony W | Executive VP, Head of R&D | 2020-12-21 | SELL | 23,551 | $149.23 | $3514.5K |
| Bolzon Bradley J PhD | Director | 2020-12-16 | SELL | 15,000 | $148.95 | $2234.3K |
| Bolzon Bradley J PhD | Director | 2020-12-10 | SELL | 33,000 | $143.35 | $4730.6K |
| Bolzon Bradley J PhD | Director | 2020-12-10 | SELL | 33,000 | $143.35 | $4730.6K |
| Kulkarni Samarth | CEO | 2020-12-10 | SELL | 20,000 | $142.29 | $2845.8K |
| Bolzon Bradley J PhD | Director | 2020-12-07 | SELL | 171,004 | $154.53 | $26425.2K |
| Novak Rodger | President | 2020-11-30 | SELL | 100,000 | $125 | $12500K |
| Novak Rodger | President | 2020-10-09 | SELL | 25,000 | $100 | $2500K |
| Bolzon Bradley J PhD | Director | 2020-09-18 | SELL | 3,035 | $86.87 | $263.7K |
| Bolzon Bradley J PhD | Director | 2020-09-16 | SELL | 8,965 | $86.98 | $779.8K |
| Bolzon Bradley J PhD | Director | 2020-09-14 | SELL | 1,155 | $84.89 | $98K |
| Bolzon Bradley J PhD | Director | 2020-09-10 | SELL | 22,845 | $85.36 | $1950K |
| TOMSICEK MICHAEL JOHN | CFO | 2020-09-01 | SELL | 12,000 | $92.26 | $1107.1K |
| Novak Rodger | President | 2020-09-01 | SELL | 25,000 | $92.62 | $2315.5K |
| Bolzon Bradley J PhD | Director | 2020-09-01 | SELL | 60,000 | $92.51 | $5550.6K |
| Novak Rodger | President | 2020-08-19 | SELL | 25,000 | $100 | $2500K |
| TOMSICEK MICHAEL JOHN | CFO | 2020-08-03 | SELL | 12,000 | $86.74 | $1040.9K |
| Novak Rodger | President | 2020-07-07 | SELL | 25,000 | $90 | $2250K |
| Bolzon Bradley J PhD | Director | 2020-07-06 | SELL | 20,000 | $82.39 | $1647.8K |
| Novak Rodger | President | 2020-07-01 | SELL | 50,000 | $80 | $4000K |
| Klein Lawrence Otto | CBO & COO | 2020-06-25 | SELL | 70,000 | $75.88 | $5311.6K |
| Ho Tony W | Executive VP, Head of R&D | 2020-06-23 | SELL | 7,158 | $75.04 | $537.1K |
| Bolzon Bradley J PhD | Director | 2020-06-23 | SELL | 20,000 | $73.93 | $1478.6K |
| Novak Rodger | President | 2020-06-23 | SELL | 50,000 | $75 | $3750K |
| Kulkarni Samarth | CEO | 2020-06-01 | SELL | 17,275 | $64.68 | $1117.3K |
| Novak Rodger | President | 2020-05-26 | SELL | 50,000 | $70.2 | $3510K |
| Ho Tony W | Executive VP, Head of R&D | 2020-05-26 | SELL | 6,700 | $70.13 | $469.9K |
| Kulkarni Samarth | CEO | 2020-05-20 | SELL | 15,000 | $65.25 | $978.8K |
| Novak Rodger | President | 2020-05-19 | SELL | 50,000 | $65 | $3250K |
| Klein Lawrence Otto | CBO & COO | 2020-05-11 | SELL | 25,000 | $60.4 | $1510K |
| Novak Rodger | President | 2019-11-19 | SELL | 33,618 | $70 | $2353.3K |
| CAGNONI PABLO J | Director | 2019-11-19 | SELL | 7,500 | $62 | $465K |
| Bolzon Bradley J PhD | Director | 2019-11-19 | SELL | 42,000 | $67.41 | $2831.2K |
| CAGNONI PABLO J | Director | 2019-11-12 | SELL | 7,500 | $55 | $412.5K |
| CAGNONI PABLO J | Director | 2019-10-30 | SELL | 7,500 | $52 | $390K |
| Bolzon Bradley J PhD | Director | 2019-10-30 | SELL | 21,000 | $51.89 | $1089.7K |
| Klein Lawrence Otto | Chief Business Officer | 2019-07-11 | SELL | 20,000 | $50.02 | $1000.4K |
| Novak Rodger | President | 2019-07-10 | SELL | 50,000 | $50 | $2500K |
| Kulkarni Samarth | CEO | 2019-06-17 | SELL | 20,000 | $46 | $920K |
| Novak Rodger | President | 2019-06-10 | SELL | 50,000 | $45 | $2250K |
| Kulkarni Samarth | CEO | 2019-04-29 | SELL | 20,000 | $42.03 | $840.6K |
| Novak Rodger | President | 2019-03-04 | SELL | 85,220 | $40.4 | $3442.9K |
| Novak Rodger | President | 2019-02-25 | SELL | 14,780 | $40 | $591.2K |
| Novak Rodger | President | 2019-01-09 | SELL | 100,000 | $35.02 | $3502K |
| Vertex Pharmaceuticals (Europe | 10% Owner | 2018-12-27 | BUY | 40,198 | $24.93 | $1002.1K |
| Vertex Pharmaceuticals (Europe | 10% Owner | 2018-12-24 | BUY | 90,742 | $24.08 | $2185.1K |
| EMSTER KURT VON | Director | 2018-12-18 | SELL | 62,925 | $29.7 | $1868.9K |
| EMSTER KURT VON | Director | 2018-12-18 | SELL | 72,934 | $29.85 | $2177.1K |
| CAGNONI PABLO J | Director | 2018-07-05 | SELL | 7,500 | $62 | $465K |
| EMSTER KURT VON | Director | 2018-06-05 | SELL | 920 | $12.51 | $11.5K |
| Kulkarni Samarth | CEO | 2018-06-01 | SELL | 15,000 | $69.36 | $1040.4K |
| Novak Rodger | President | 2018-05-17 | SELL | 75,000 | $60 | $4500K |
| Bolzon Bradley J PhD | Director | 2018-05-15 | SELL | 44,000 | $57.99 | $2551.6K |
| Woiwode Thomas | Director | 2018-05-15 | SELL | 44,000 | $57.99 | $2551.6K |
| EMSTER KURT VON | Director | 2018-05-14 | SELL | 650,000 | $54.39 | $35353.5K |
| Woiwode Thomas | Director | 2018-05-08 | SELL | 121,362 | $50.39 | $6115.4K |
| Bolzon Bradley J PhD | Director | 2018-05-08 | SELL | 128,950 | $50.39 | $6497.8K |
| Woiwode Thomas | Director | 2018-04-30 | SELL | 30,566 | $50.29 | $1537.2K |
| Bolzon Bradley J PhD | Director | 2018-04-30 | SELL | 30,566 | $50.29 | $1537.2K |
| Bolzon Bradley J PhD | Director | 2018-04-27 | SELL | 222,258 | $50.11 | $11137.3K |
| Woiwode Thomas | Director | 2018-04-27 | SELL | 222,258 | $50.11 | $11137.3K |
| Woiwode Thomas | Director | 2018-04-24 | SELL | 22,841 | $50.99 | $1164.7K |
| Bolzon Bradley J PhD | Director | 2018-04-24 | SELL | 22,841 | $50.99 | $1164.7K |
| Versant Venture Capital V, L.P | 10% Owner | 2018-04-24 | SELL | 22,841 | $50.99 | $1164.7K |
| Versant Side Fund IV, L.P. | 10% Owner | 2018-04-23 | SELL | 101,994 | $50.68 | $5169.1K |
| Woiwode Thomas | Director | 2018-04-23 | SELL | 101,994 | $50.68 | $5169.1K |
| Bolzon Bradley J PhD | Director | 2018-04-23 | SELL | 101,994 | $50.68 | $5169.1K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2018-01-16 | SELL | 66,000 | $28.03 | $1850K |
| EMSTER KURT VON | Director | 2018-01-05 | SELL | 92,337 | $26.96 | $2489.4K |
| BAYER AKTIENGESELLSCHAFT | 10% Owner | 2018-01-05 | BUY | 527,472 | $22.75 | $12000K |
| EMSTER KURT VON | Director | 2018-01-05 | BUY | 65,934 | $22.75 | $1500K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2018-01-02 | SELL | 38,000 | $21.64 | $822.3K |
| EMSTER KURT VON | Director | 2018-01-02 | SELL | 37,754 | $26.76 | $1010.3K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-12-29 | SELL | 31,000 | $22.72 | $704.3K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-12-22 | SELL | 15,000 | $20.55 | $308.3K |
| Bolzon Bradley J PhD | Director | 2017-12-22 | SELL | 26,016 | $20.3 | $528.1K |
| Woiwode Thomas | Director | 2017-12-22 | SELL | 3,059 | $20.29 | $62.1K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-12-15 | SELL | 15,000 | $18.9 | $283.5K |
| CELGENE CORP /DE/ | 10% Owner | 2017-12-04 | SELL | 1,112,446 | $18.98 | $21114.2K |
| Woiwode Thomas | Director | 2017-11-27 | SELL | 1,900 | $20.21 | $38.4K |
| Bolzon Bradley J PhD | Director | 2017-11-27 | SELL | 1,707 | $20.21 | $34.5K |
| Novak Rodger | CEO | 2017-09-05 | SELL | 18,470 | $20.76 | $383.4K |
| Novak Rodger | CEO | 2017-08-30 | SELL | 75,795 | $20.25 | $1534.8K |
| Kulkarni Samarth | Chief Business Officer | 2017-08-30 | SELL | 27,154 | $20.08 | $545.3K |
| EMSTER KURT VON | Director | 2017-08-28 | SELL | 88,011 | $19.79 | $1741.7K |
| EMSTER KURT VON | Director | 2017-08-25 | SELL | 22,781 | $19.42 | $442.4K |
| EMSTER KURT VON | Director | 2017-08-23 | SELL | 17,989 | $18.53 | $333.3K |
| EMSTER KURT VON | Director | 2017-08-21 | SELL | 3,150 | $18.52 | $58.3K |
| EMSTER KURT VON | Director | 2017-08-17 | SELL | 34,141 | $19.06 | $650.7K |
| EMSTER KURT VON | Director | 2017-08-15 | SELL | 55,569 | $19.59 | $1088.6K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-08-08 | SELL | 15,000 | $18.57 | $278.6K |
| EMSTER KURT VON | Director | 2017-08-08 | SELL | 35,473 | $18.63 | $660.9K |
| EMSTER KURT VON | Director | 2017-08-04 | SELL | 50,477 | $17.81 | $899K |
| EMSTER KURT VON | Director | 2017-08-01 | SELL | 5,512 | $17.51 | $96.5K |
| EMSTER KURT VON | Director | 2017-07-28 | SELL | 41,312 | $17.63 | $728.3K |
| EMSTER KURT VON | Director | 2017-07-26 | SELL | 32,930 | $17.6 | $579.6K |
| EMSTER KURT VON | Director | 2017-07-14 | SELL | 69,859 | $16.84 | $1176.4K |
| EMSTER KURT VON | Director | 2017-07-12 | SELL | 31,992 | $16.56 | $529.8K |
| EMSTER KURT VON | Director | 2017-07-05 | SELL | 4,254 | $16.26 | $69.2K |
| EMSTER KURT VON | Director | 2017-06-29 | SELL | 43,202 | $16.9 | $730.1K |
| EMSTER KURT VON | Director | 2017-06-27 | SELL | 81,435 | $17.08 | $1390.9K |
| EMSTER KURT VON | Director | 2017-06-23 | SELL | 32,368 | $16.23 | $525.3K |
| Novak Rodger | CEO | 2017-06-22 | SELL | 10,825 | $15.37 | $166.4K |
| Novak Rodger | CEO | 2017-06-21 | SELL | 30,222 | $15.01 | $453.6K |
| Novak Rodger | CEO | 2017-06-09 | SELL | 5,303 | $15.02 | $79.7K |
| Novak Rodger | CEO | 2017-05-30 | SELL | 3,650 | $15.02 | $54.8K |
| Novak Rodger | CEO | 2017-05-17 | SELL | 50,000 | $16.26 | $813K |
| Novak Rodger | CEO | 2017-05-05 | SELL | 616 | $16.92 | $10.4K |
| Novak Rodger | CEO | 2017-05-04 | SELL | 49,384 | $16.3 | $805K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-05-01 | SELL | 1,852 | $16.61 | $30.8K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-04-28 | SELL | 21,639 | $16.78 | $363.1K |
| Kulkarni Samarth | Chief Business Officer | 2017-04-27 | SELL | 5,481 | $16.76 | $91.9K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-04-25 | SELL | 11,332 | $16.78 | $190.2K |
| Kulkarni Samarth | Chief Business Officer | 2017-04-25 | SELL | 11,615 | $16.78 | $194.9K |
| Novak Rodger | CEO | 2017-04-20 | SELL | 50,000 | $17.88 | $894K |
| Kulkarni Samarth | Chief Business Officer | 2017-04-20 | SELL | 10,058 | $17.73 | $178.3K |
| Dylan-Hyde Tyler | Chief Legal Officer | 2017-04-20 | SELL | 10,177 | $17.71 | $180.2K |
| CELGENE CORP /DE/ | 10% Owner | 2016-10-24 | BUY | 800,150 | $14 | $11202.1K |
| Lundberg Sven Ante | Chief Scientific Officer | 2016-10-24 | BUY | 400 | $14 | $5.6K |
| George Simeon | Director | 2016-10-24 | BUY | 66,500 | $14 | $931K |
| GLAXOSMITHKLINE PLC | 10% Owner | 2016-10-24 | BUY | 66,500 | $14 | $931K |
| CELGENE CORP /DE/ | 10% Owner | 2016-10-24 | BUY | 800,150 | $14 | $11202.1K |
| EMSTER KURT VON | Director | 2016-10-24 | BUY | 56,000 | $14 | $784K |
| Versant Side Fund IV, L.P. | 10% Owner | 2016-10-24 | BUY | 161,000 | $14 | $2254K |
| Woiwode Thomas | Director | 2016-10-24 | BUY | 161,000 | $14 | $2254K |
| Bolzon Bradley J PhD | Director | 2016-10-24 | BUY | 161,000 | $14 | $2254K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked